Testicular cancer and the tuberous sclerosis complex

Acta Oncologica

Volumn 51, Issue 2, 2012, Pages 262-265

  Tandstad, Torgrim ^a   Indrebø, Gunnar ^b  

^a TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^b A lesund Hospital   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; ANTINEOPLASTIC AGENT; CARBOPLATIN; CHORIONIC GONADOTROPIN;

ADULT; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER RADIOTHERAPY; CASE REPORT; ECHOGRAPHY; HAMARTOMA; HEARING IMPAIRMENT; HISTOLOGY; HUMAN; HUMAN TISSUE; INTELLECTUAL IMPAIRMENT; LANGUAGE DISABILITY; LETTER; LUNG METASTASIS; MALE; MALIGNANT TRANSFORMATION; NORWAY; NUCLEAR MAGNETIC RESONANCE IMAGING; ORCHIECTOMY; PALLIATIVE THERAPY; PREVALENCE; PRIORITY JOURNAL; RETROPERITONEAL CANCER; SEIZURE; SUBEPENDYMOMA; TESTIS CANCER; TUBEROUS SCLEROSIS;

ADULT; DIAGNOSIS, DIFFERENTIAL; FATAL OUTCOME; HUMANS; MALE; TESTICULAR NEOPLASMS; TUBEROUS SCLEROSIS;

EID: 84856428465     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2011.587450     Document Type: Letter

References (12)

1. Osborne JP, Fryer A, Webb D. Epidemiology of tuberous sclerosis. Ann N Y Acad Sci 1991;615:125-7.
2. von Reclinghausen F. Ein Herz von einem Neugeborene welches mehrere theils nach aussen, theils nach den H ö hlen prominirende Tumoren (Myomen) trug. Monatsschr Geburtsheilk 1862;20:1-2. German.
3. Bourneville D. Sclerose tuberuse des circonvolutions cerebrales: Idiotie et epilepsie hemiplegie. Arch Neurol (Paris) 1880;1:81-91. French.
4. Curatolo P, Bombardieri R, Jozwiak S. Tuberous sclerosis. Lancet 2008;372(9639):657-68.
5. Dabora SL, Jozwiak S, Franz DN, Roberts PS, Nieto A, Chung J, et al. Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2 compared with TSC1, disease in multiple organs. Am J Hum Genet 2001;68:64-80.
6. Kwiatkowski DJ, Manning BD. Tuberous sclerosis: A GAP at the crossroads of multiple signaling pathways. Hum Mol Genet 2005;14 Spec No. 2:R251 - 8.
7. Freilinger A, Rosner M, Krupitza G, Nishino M, Lubec G, Korsmeyer SJ, et al. Tuberin activates the proapoptotic molecule BAD. Oncogene 2006;25:6467-79.
8. Bray F, Grimsrud T, Haldorsen T. Cancer Registry of Norway. Cancer in Norway 2008 - Cancer incidence, mortality, survival and prevalence in Norway. Oslo: Cancer Registry of Norway; 2009.
9. Oosterhuis JW, Looijenga LH. Testicular germ-cell tumours in a broader perspective. Nat Rev Cancer 2005;5: 210-22.
10. Moul JW, Paulson DF, Dodge RK, Walther PJ. Delay in diagnosis and survival in testicular cancer: Impact of effective therapy and changes during 18 years. J Urol 1990;143:520-3.
11. Prout GR, Jr., Griffi n PP. Testicular tumors: Delay in diagnosis and infl uence on survival. Am Fam Physician 1984;29:205-9.
12. International Germ Cell Consensus Classifi cation: A prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group. J Clin Oncol 1997;15:594-603.